跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SELANZ SR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SELANZ SR
Approved
STANDARD
SELANZ SR
The Searle Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab28f4b2b92692bd
Company
The Searle Company Limited
Type
Standard
Approval Details
Approval Id
ab28f4b2b92692bd
Drug Approval Philippines Name
SELANZ SR
Product Name
SELANZ SR
Registration Number
DRP-3509
Brand Name
SELANZ SR
Generic Name
Lansoprazole
Dosage Form
Capsule
Dosage Strength
30 mg
Manufacturer
The Searle Company Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/the-searle-company-limited
Issuance Date
04 August 2023
Expiry Date
18 January 2029
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab28f4b2b92692bd
Type
Standard
Back to Philippines FDA Approvals